Merit Medical Systems (MMSI) Depreciation & Amortization (CF) (2010 - 2026)

Merit Medical Systems has disclosed Depreciation & Amortization (CF) across 17 years of filings, most recently posting $30.5 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $30.5 million, up 4.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $124.4 million (up 14.73% YoY), and the FY2025 annual result was $123.2 million, up 19.92% from the prior year.
• Depreciation & Amortization (CF) came in at $30.5 million for Q1 2026 at Merit Medical Systems, down from $31.5 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $31.5 million in Q4 2025 to a low of $20.4 million in Q3 2022.
• The 5-year median for Depreciation & Amortization (CF) is $24.0 million (2023), against an average of $25.2 million.
• Across the five-year window, Depreciation & Amortization (CF) decreased 4.36% in 2022 and grew 28.77% in 2025, its largest moves.
• Merit Medical Systems' Depreciation & Amortization (CF) stood at $20.5 million in 2022, then gained by 15.29% to $23.6 million in 2023, then gained by 21.12% to $28.6 million in 2024, then grew by 10.21% to $31.5 million in 2025, then fell by 3.29% to $30.5 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $30.5 million (Q1 2026), $31.5 million (Q4 2025), and $31.3 million (Q3 2025), per Business Quant data.